SAN FRANCISCO — The executives and investors who flew here from all over the world for the drug industry’s annual confab this week brought with them presentations, elevator pitches — and, well, lots of bugs. Especially on their smartphones.

That’s why Weill Cornell Medicine researchers are conducting a study at the J.P. Morgan Healthcare Conference to analyze the DNA of the microbes on attendees’ cell phones. They want to see whether cities leave a distinct microbial footprint on their residents’ iPhones.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X